Regeneron 23andMe Acquisition

News

Ann Wojcicki's TTAM to Acquire 23andMe for $305M

Regeneron Backs Off 23andMe, Losing Bid to Former CEO

Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.

MedTech Dive · 43m

Anne Wojcicki wins bid to buy back 23andMe for $305M

A nonprofit led by the co-founder and former CEO of 23andMe outbid competitors for nearly all of the company’s assets.

CNN on MSN · 2d

Anne Wojcicki’s nonprofit wins bid to acquire genetic testing company 23andMe

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

23h

Anne Wojcicki’s nonprofit reaches deal to acquire 23andMe

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

20hon MSN

23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company

Former 23andMe CEO Anne Wojcicki outbids Regeneron with a $305 million offer through her nonprofit TTAM to regain control of the DNA-testing company she co-founded.

ConsumerAffairs7d

States file suit to block the sale of 23andMe data

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

States Challenge 23andMe Over Genetic Data Sale in Bankruptcy Deal

States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...

STAT5dOpinion

I’m adopted. I still won’t use genetic testing services like 23andMe

A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results